phenylbenzimidazolesulfonic acid
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00530387)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUltraviolet filter
ultraviolet filter
Chemistry & pharmacology
Loading structure…
SMILES
O=S(=O)(O)c1ccc2[nH]c(-c3ccccc3)nc2c1- Mol. weight
- 274.3 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1987518 ↗
Also known as
- 2-phenylbenzimidazole-5-sulfonic acid
- 2-phenylbenzimidazole-5-sulfonic acid, monosodium salt
- ensulizole
- ensulizole
- ensulizole
- ensulizole
- ensulizole
- ensulizole
- eusolex 232
- eusolex 232
- novantisol
- phenylbenzimidazole sulfonic acid
- phenylbenzimidazole sulfonic acid
- phenylbenzimidazole sulfonic acid
- phenylbenzimidazole sulfonic acid
- phenylbenzimidazole sulfonic acid
- phenylbenzimidazole sulfonic acid
- phenylbenzimidazolesulfonic acid
- phenylbenzimidazole sulphonic acid
- phenylbenzimidazole sulphonic acid
- phenylbenzimidazol sulfonic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01001975 | Phase 3 | Jul 1, 2009 | Bayer |
| NCT00530387 | N/A | Jul 1, 2008 | University of Dundee |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 1 | 1 | 1 | 2009 |
| University of Dundee | Academic/Hospital | 1 | 1 | 1 | 2008 |
2 organizations
Page 1 / 1